Nowadays, circulating EBV DNA [6–8], serum lactate dehydrogenase (LDH) [9], C-reactive protein (CRP) [10], and systemic immune-inflammation index (SII) [11] have been demonstrated to influence recurrence and survival in NPC patients. Here, CRP is linked to nasopharyngeal carcinoma.